| Survival |
Group A (tri modality therapy) |
Group B (bi modality therapy) no chemotherapy |
P value |
| After start of therapy |
19 (100%) |
23 (100%) |
|
| By the end of therapy |
18 (95%) |
21 (91%) |
| 1st year |
16 (84%) |
19 (82%) |
| 2nd year |
16 (84%) |
18 (77%) |
| 3rd year |
15 (78%) |
15 (62%) |
| 4th year |
15 (78%) |
11 (44%) |
| 5th year |
13 (68%) |
9 (39%) |
| 5-year survival rate |
68% |
39% |
0.001 |
|